Abstract

Carbidopa 1.25-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2007 - Pediatric Patients

Page(s): 70

Download in electronic PDF format for $75
  • Carbidopa 1.25-mg/mL Oral Liquid Page 1

Abstract

A formulation for preparing Carbidopa 1.25-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • FORMULATIONS, CARBIDOPA, LIQUID PREPARATIONS, CHILDREN, EYE DISORDERS, VISION DISORDERS, DOPAMINE AGONIST, AMBLYOPIA, PARKINSONISM, PARKINSON'S DISEASE, ELDERLY

Related Categories

  • FORMULATIONS
  • GERIATRICS
  • OPHTHALMICS
  • PEDIATRICS
  • DOSAGE FORMS/DRUG CARRIERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2007
Pg. 70
Carbidopa 1.25-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 145
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 149
Levodopa and Carbidopa Rectal Suspension
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jan/Feb 2004
Pg. 46-48
Basics of Compounding for Disorders of the External Ear
Author(s): Allen Loyd V Jr
Jan/Feb 2001
Pg. 6-8
Pediatric Compounding: Coloring Outside the Lines
Author(s): Preckshot John
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2002
Pg. 202
Carbidopa 2-mg/mL and Levodopa 250-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 410
Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 421
Metoprolol Tartrate 1.25-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2000
Pg. 276-279
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease
Author(s): Glasnapp Andrew, Schaefer Erin
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Jul/Aug 2003
Pg. 304
Triprolidine HCl 1.25-mg/5-mL, Pseudoephedrine HCl 30-mg/5-mL and Codeine Phosphate 10-mg/5-mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2007
Pg. 220-225
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2
Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Nov/Dec 2019
Pg. 487
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Author(s): Allen Loyd V Jr
May/Jun 2020
Pg. 229
Prednisolone 1 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 435-437
Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations
Author(s): Yamreudeewong Weeranuj, Dolence Eric Kurt, Teixeira M Glaucia